The further synergistic combination approach with other gastrointestinal hormones and creation of dual GIP/GLP-1 receptor agonists, such as tirzepatide and GLP-1/GIP/glucagon receptor triagonist, retatrutide, has shown unprecedented pharmacologically achieved weight loss with further cardiometabolic benefits in both obesity and T2DM
Regular monitoring while on a weight loss drug is important to check for side effects, assess effectiveness, and make changes to the medication or dose, if needed
doi:10.1007/s00216-015-8481-0 22
By inhibiting the insulin antagonist glucagon, they also stimulate the satiety center in the brain
If you are considering the new Wegovy tablet, injectable Wegovy, or Mounjaro, expert clinical guidance can help you choose the treatment that is most likely to deliver safe, sustainable and lasting results